OncoGenex Pharmaceuticals (OGXI) Jumps: Stock Rises 5.8% – Tale of the Tape

February 11, 2014 Technicals 0

Zacks

OncoGenex Pharmaceuticals, Inc. (OGXI) was a big mover last session with its shares rising nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock has gained nearly 30% in the past one-month time frame.

This biopharmaceutical company has seen no estimate revision in the last 30 days. The Zacks Consensus Estimate hasn’t remained in trend either. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

OncoGenex currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Some better-ranked Med-Drug stocks include Lannett Company, Inc. (LCI), Endocyte, Inc. (ECYT) and BioCryst Pharmaceuticals, Inc. (BCRX). While LCI and ECYT sport a Zacks Rank #1 (Strong Buy), BCRX carries a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply